Join to View Full Profile
2219 Bath St"# William"Santa Barbara, CA 93105
Phone+1 805-682-7640
Fax+1 805-682-3332
Are you Dr. Pinsker?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jordan Pinsker, MD is a pediatric endocrinologist in Santa Barbara, California. He is currently licensed to practice medicine in California, Hawaii, and Texas.
Education & Training
National Capital ConsortiumFellowship, Pediatric Endocrinology, 2004 - 2007
San Antonio Uniformed Services Health Education ConsortiumResidency, Pediatrics, 2001 - 2004
Albany Medical CollegeClass of 2001
Certifications & Licensure
CA State Medical License 2003 - 2026
HI State Medical License 2008 - 2016
TX State Medical License 2002 - 2009
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Endocrinology
American Board of Preventive Medicine Clinical Informatics
Publications & Presentations
PubMed
- Glycemic and Patient-Reported Outcomes for Users of a New, Compact Automated Insulin Delivery System: A First Report.Halis K Akturk, Kagan E Karakus, Edwin D'Souza, Kimia Z Assadi, Jordan E Pinsker
Journal of Diabetes Science and Technology. 2025-03-01 - Randomized, Crossover Trial of Control-IQ Technology with a Lower Treatment Range and a Modified Meal Bolus Module in Adults, Adolescents, Children, and Preschoolers w...Sue A Brown, Lori M Laffel, Halis K Akturk, Gregory P Forlenza, Viral N Shah
Diabetes Technology & Therapeutics. 2025-03-01 - Safety and Feasibility Evaluation of Automated User Profile Settings Initialization and Adaptation With Control-IQ Technology.Viral N Shah, Halis K Akturk, Alex Trahan, Nicole Piquette, Alex Wheatcroft
Journal of Diabetes Science and Technology. 2024-11-01
Press Mentions
Tandem Has Positive Data for Automated Insulin Delivery in Type 2 Diabetes PopulationMarch 19th, 2025
Tandem Diabetes Care Receives FDA Clearance for Control-IQ+ Technology for Type 2 DiabetesFebruary 25th, 2025
Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 DiabetesFebruary 25th, 2025- Join now to see all
